SMS Pharmaceuticals Ltd.

SMS Pharmaceuticals Limited is a leading publicly listed API/intermediates manufacturer with USFDA, EU GMP (Germany), TGA and Japan PMDA qualified sites. The company began operations in 1990 and serves leading generic and innovator firms, operating seven manufacturing facilities in and near Hyderabad, India, along with a state-of-the-art R&D center with synthesis, analytical and scale-up facilities in Hyderabad; the company operates in the anti-ulcer, anti-fungal, anti-migraine, anti-hypertensive and antiretroviral therapeutic segments.